Safety Problems Roil Pharma and FDA

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2004, Volume 28, Issue 11

Blockbuster drugs turn out to be risky business, while contamination problems shut down flu vaccine production.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-12-02-2004
The European Commission Approves Severe Alopecia Areata Treatment
EC Approves Fixed-Dose Oral Combination Treatment for AML
Staying Compliant in 2023